Wu, F., Zeng, Y., Peng, Y., Pu, X., Liu, P., Ma, F., Qiu, Z., Zhang, L., Zhou, Y., Bu, Q., Zhou, C., Weng, J., Yu, J., Meng, R., Liu, H., Zhou, Z., Sheng, Z., Xu, C., Wang, H., Yang, W. (2026). Longitudinal circulating tumor DNA surveillance as predictor of progression in advanced non-small-cell lung cancer with long-term benefit to immunotherapy.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.8540